Tag: Early Feasibility Studies

In an article by MD+DI, MDIC expressed strong support for Dr. Tarver’s appointment, recognizing her visionary leadership and dedication to improving patient care.

Following a meeting at the MDIC Annual Public Forum, Maryellen de Mars, MDIC’s program director of clinical diagnostics, said in an interview that the consortium’s Somatic Reference Samples Initiative recently confirmed that it has successfully engineered the 10 target reference lines and is ready to start its next steps to confirm its results and establish use cases.

Following a meeting at the MDIC Annual Public Forum, Maryellen de Mars, MDIC’s program director of clinical diagnostics, said in an interview that the consortium’s Somatic Reference Samples Initiative recently confirmed that it has successfully engineered the 10 target reference lines and is ready to start its next steps to confirm its results and establish use cases.

Discover how the FDA’s Early Feasibility Study (EFS) program is transforming U.S. clinical research and accelerating the development of innovative medical technologies.